Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)

NCT00090298 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2815

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: MK0653A, ezetimibe (+) simvastatin
DRUG: Comparator: Rosuvastatin

Sponsor

Organon and Co